BridgeMD
New treatment option for Postpartum Hemorrhage
Official title Umbilical Cord Drainage to Prevent Postpartum Hemorrhage
ClinicalTrials.gov ID: NCT07401160
What this study is testing
- What it's testing
- This study aims to analyze whether there is a significant difference in the occurrence of postpartum hemorrhage between women who underwent umbilical cord drainage and those who did not. Variables such as estimated blood loss volume, drop in hemoglobin levels, and the need for additional maneuvers or treatments to control hemorrhage will be examined.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 49, women only. Healthy volunteers may be eligible.
You may be able to join if
- Pregnant women aged 18-49 years.
- Singleton pregnancy.
- Gestational age ≥37 weeks.
- active labor with cephalic presentation.
- Planned for vaginal delivery.
You likely can't join if
- Planned or emergent cesarean section.
- Instrumental delivery (e.g., forceps, vacuum).
- Antepartum hemorrhage.
- Severe anemia (Hemoglobin \<8 g/dL) or specific hematological disorders (e.g., sickle cell disease, thalassemia, hemophilia, thrombocytopenia...
- Use of anticoagulant medication.
- Non-cephalic fetal presentation (e.g., breech, transverse).
See the full eligibility criteria
- Pregnant women aged 18-49 years.
- Singleton pregnancy.
- Gestational age ≥37 weeks.
- active labor with cephalic presentation.
- Planned for vaginal delivery.
- Capable of providing informed consent.
- Planned or emergent cesarean section.
- Instrumental delivery (e.g., forceps, vacuum).
- Antepartum hemorrhage.
- Severe anemia (Hemoglobin \<8 g/dL) or specific hematological disorders (e.g., sickle cell disease, thalassemia, hemophilia, thrombocytopenia \<100,000/µL).
- Use of anticoagulant medication.
- Non-cephalic fetal presentation (e.g., breech, transverse).
- Refusal to participate or inability to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Tegucigalpa, Francisco Morazán Department, Honduras
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 49 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tegucigalpa, Francisco Morazán Department, Honduras. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.